[HTML][HTML] Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning

Y Shoenfeld - Autoimmunity reviews, 2020 - ncbi.nlm.nih.gov
The 2020 coronavirus epidemic is characterized by high infectious rates and relatively high
mortality, especially among the elderly over the age of 80. In this issue we published two …

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

S Colafrancesco, C Alessandri, F Conti, R Priori - Autoimmunity reviews, 2020 - Elsevier
The severe form of COVID-19 share several clinical and laboratory features with four entities
gathered under the term “hyperferritinemic syndromes” and including macrophage activation …

Covid-19 and autoimmunity

M Ehrenfeld, A Tincani, L Andreoli, M Cattalini… - Autoimmunity …, 2020 - Elsevier
Though the exact etiology of autoimmune diseases still remains unknown, there are various
factors which are believed to contribute to the emergence of an autoimmune disease in a …

Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome. An immunomodulatory perspective to alleviate the storm

P Ruscitti, O Berardicurti, P Di Benedetto… - Frontiers in …, 2020 - frontiersin.org
The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by severe
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has been declared as a …

COVID-19: an immunopathological view

K Kadkhoda - MSphere, 2020 - Am Soc Microbiol
Since its emergence in December 2019, it took only a couple of months for an outbreak of
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - Elsevier
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

Y Jamilloux, T Henry, A Belot, S Viel, M Fauter… - Autoimmunity …, 2020 - Elsevier
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …

COVID-19: infection or autoimmunity

T Icenogle - Frontiers in immunology, 2020 - frontiersin.org
The clinical and laboratory features of COVID-19 are reviewed with attention to the
immunologic manifestations of the disease. Recent COVID-19 publications describe a …

SARS-CoV-2: immune response elicited by infection and development of vaccines and treatments

G Canedo-Marroquin, F Saavedra… - Frontiers in …, 2020 - frontiersin.org
The World Health Organization (WHO) announced in March a pandemic caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …